Concepedia

Lorri L. Short

LL

Statistics

Publications

13

Citations

1.2K

H-Index

13

Active since

1995

Affiliations

Eli Lilly (United States)(Current)

Lorri L. Short is an author at Eli Lilly (United States) specializing in medicinal chemistry, molecular pharmacology, and pharmacology.

Publications per year

1995–2001

13

Publications

13

Discovery and Synthesis of [6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]- 2-(4-hydroxyphenyl)]benzo[<i>b</i>]thiophene:  A Novel, Highly Potent, Selective Estrogen Receptor Modulator

Alan D. Palkowitz, Andrew L. Glasebrook, K. Jeff Thrasher et al. · Journal of Medicinal Chemistry · 1997 · 177 citations

, , +7

Structure−Activity Relationships of Selective Estrogen Receptor Modulators:  Modifications to the 2-Arylbenzothiophene Core of Raloxifene

Timothy A. Grese, Stephen Cho, Don R. Finley et al. · Journal of Medicinal Chemistry · 1997 · 176 citations · Full text

, , +12

Environmental estrogens: Effects on cholesterol lowering and bone in the ovariectomized rat

Jeffrey A. Dodge, Andrew L. Glasebrook, David E. Magee et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1996 · 150 citations

, , +16

Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues:  Highly Potent Selective Estrogen Receptor Modulators

Timothy A. Grese, Lewis D. Pennington, James P. Sluka et al. · Journal of Medicinal Chemistry · 1998 · 126 citations

, , +17

Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.

Masahiko Sato, J Kim, Lorri L. Short et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 120 citations

, , +16

1–5 of 13